Sartorius Reports Nine-Month Results, Confirms Full-Year Outlook
Sartorius said revenue and earnings grew in the first nine months of 2026, exceeding expectations, and confirmed full-year guidance for the group and Bioprocess Solutions division. Third-quarter results were slightly below some expectations.
Sartorius reported higher revenue and earnings for the first nine months of 2026, with both figures exceeding expectations. The company attributed the performance to positive business development and favorable conditions in relevant end markets. Management confirmed its full-year guidance for the group and the Bioprocess Solutions division. Third-quarter results were slightly below some expectations, while the nine-month performance reflected a continued positive trajectory.